• Exchange: Natl India
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Panacea Biotec Ltd

+ Add to Watchlist


147.40 INR 0.75 0.51%

As of 05:00:01 ET on 12/29/2014.

Snapshot for Panacea Biotec Ltd (PNCB)

Open: 149.70 Day's Range: 146.10 - 151.45 Volume: 86,884
Previous Close: 148.15 52wk Range: 88.60 - 219.35 1-Yr Rtn: +40.31%

Stock Chart for PNCB

No chart data available.
  • PNCB:IN 147.40
  • 1D
  • 1M
  • 1Y
Interactive PNCB Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for PNCB

Current P/E Ratio (ttm) -
Estimated P/E(-) -
Relative P/E vs. SENSEX -
Earnings Per Share (ttm) -18.3100
Est. EPS -
Est. PEG Ratio -
Market Cap (M INR) 9,055.92
Shares Outstanding (M) 61.25
30 Day Average Volume 104,078
Price/Book (mrq) 1.7609
Price/Sale (ttm) 1.7518
Dividend Indicated Gross Yield -%
Cash Dividend (INR) 0.7500
Dividend Ex-Date 09/19/2011
5 Year Dividend Growth -
Next Earnings Announcement 05/29/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for PNCB

  • Revenue
  • Net Income (M/INR)
  • Profit Margin (%)

Company Profile & Key Executives for PNCB

Panacea Biotec Limited operates a pharmaceutical company in India, which manufactures a variety of drugs that are distributed internationally. The Company's products are available in an assortment of forms, including tablets, capsules, dry powder injectables, vaccines, gels, and syrups. Pancea Biotec's key products include a Hepatitis B vaccine and drugs for diabetes management.

Soshil Kumar JainChairmanRavinder Kumar JainManaging Director
Rajesh JainJoint Managing DirectorSandeep JainJoint Managing Director
More Company Profile & Key Executives for PNCB

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil